🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recent advancements have led to a doubling of life expectancy of patients with #metastatic #bladdercancer, says Petros Grivas. He sat down with Dr. Jonathan Wright to discuss the latest in treatment for #bladdercancerawarenessmonth. Watch: bit.ly/3Z0g9d7

Congratulations to Dr. Ann Oluloro, a fellow in our Gynecologic Oncology program, who was nominated and selected for a 2025 Outstanding Underserved Pathway Mentor Award! #obgyn #mentorship #MedEd Learn more about the pathway at buff.ly/vQuK0j3

An #ASCO25 prelude, celebrating my mentor, friend, and partner-in-crime for CUP, Kanwal Raghav 🩺 🖖🏻 whose sole author clinical practice review of CUP was published in NEJM. 💯 would recommend! MD Anderson Cancer Center nejm.org/doi/full/10.10…

Congrats to all ASCO Conquer Cancer, the ASCO Foundation YIA recipients! This a great milestone & honor! Proud of our own junior Faculty Ruben Raychaudhuri Fred Hutch Cancer Center for this award, kudos to him & his mentors Dr. Schweizer et al. Nicole D. Fleming MD Dr. Tom Lynch OncoAlert Prostate Cancer Foundation Hsieh Lab #ASCO25

ASCO Jeremy Ramdial Our fellow Ji (Jessica) Son presented promising results for a heavily pretreated population from the EON Phase II trial of etigilimab and nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer. Shannon Westin, MD, MPH, FASCO ASCO #ASCO25 #EndCancer

🧵 1/ Can a 7-month study predict what a 7-year trial confirms? The #SUROVA study just did something astonishing. The #TRUST trial results were released at #ASCO25… and they perfectly mirror SUROVA’s findings. Here’s why that matters. 👇

🙌ROSELLA ! Overall survival benefit (👍PFS benefit too) with the addition of relacorilant (glucocorticoid antagonist) to nab-paclitaxel in platinum resistant #ovariancancer 🎉🔥Another big win for our patients!!! #ASCO25 #gyncsm

Original Article: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer (CHALLENGE phase 3 trial) nej.md/4mh5RPL #ASCO25 | ASCO

You might say it's “just heavy periods.” You might call it “something to watch.” But what if it’s more? Uterine Cancer Awareness Month is a reminder to speak up, follow up, and check in. #AskHer. Then listen. Learn more about uterine/endometrial cancer: shorturl.at/bQO47

Impactful day presenting YOUR voice and needs, to the delegation from ARPA-H & Congressman Dan Crenshaw's office related to Project THOR pioneered by Biotech Launch Pad. Project THOR promises to bring forth a novel treatment for #ovariancancer and we are here for it! #WeOvarcome!

Connect, share knowledge, and get inspired at the SGO 2025 Allied Health Professionals Meeting, October 10–12 in Denver. Dive into the latest advancements in gynecologic oncology care. Register today and elevate your expertise: ow.ly/lMGX50W3HQG #SGOMtg

Timely and much-needed recommendations from ASCO We hope academic medical centers implement them without delay—for the well-being of oncologists and the future of cancer care. ASCO Journal of Clinical Oncology OncoAlert Eric Winer, MD Clifford Hudis Julie Gralow Jame Abraham, MD, FACP Erika Hamilton, MD

Targeting lineage plasticity in #ProstateCancer with EZH2 inhibitor mevrometostat. Michael Schweizer Fred Hutch Cancer Center sits down with Oliver Sartor, MD Mayo Clinic diving into #mevrometostat—an #EZH2 inhibitor tackling lineage plasticity in #mCRPC. Adding it to enzalutamide slashed

📣 1 in 36. That’s how many women will face uterine cancer in their lifetime. It’s time we start treating it like the major health issue it is. Ask the questions. Know the symptoms. Share the facts. Learn more: shorturl.at/8LoGZ #AskHer #WomensHealth #CancerEducation

🚨 We’re recruiting! Fred Hutch Cancer Center is seeking a clinician scholar in multiple myeloma — an incredible opportunity to join a world-class team, lead cutting-edge clinical research, and care for patients at a premier academic center. Outstanding environment. Unparalleled resources.

Fred Hutch Cancer Center is Seeking a Clinician Scholar in Multiple Myeloma - Mazyar Shadman Mazyar Shadman, MD MPH Fred Hutch Cancer Center oncodaily.com/blog/mazyar-sh… #Cancer #Medicine #Health #Myeloma #Job #MedX #MedNews #MedEd #Oncology #OncoDaily

Vyshak Alva Venur Became Associate Professor of Medicine at the University of Washington and Fred Hutch Cancer Center Fred Hutch Cancer Center University of Washington oncodaily.com/career/vyshak-… #Health #Oncology #OncoDaily #Medicine #Cancer CancerWorld

We are BACK with season 6!☕️ We are honored to welcome Global Expert Dr. Tyler Hillman as we dive deep into Granulosa Cell Tumors & learn about the latest advances. SUBSCRIBE to our #YouTube to never miss an episode. Learn. Share. Be Empowered! 💪 Let's #ConnectOvarCoffee!

Congratulations to Petros Grivas on receiving the 2025 Young Investigator Award from ECOG-ACRIN Cancer Research Group! He's recognized for a distinguished record of innovative research, outstanding clinical practice, and unwavering dedication to advancing the field of genitourinary oncology.

July 10 and July 12 - join us! Connect Ovar Coffee ☕️ on our YouTube Teal Truths Online Group Counseling Series via this link: us02web.zoom.us/meeting/regist… Learn. Share. Mingle. #Ovarcome!